$XNET Balance Sheet | Understand Stock

$XNET

$3.86 +$0.02 (0.52%) Close

$XNET Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net (Allowance for current expected credit losses of US$1,258 and US$1,471 as of December 31, 2024 and 2025, respectively)
Inventories
Deferred tax assets
Due from related parties (Allowance for current expected credit losses of USD339 and USD639 as of December 31, 2021 and 2022, respectively)
Due from related parties (Allowance for current expected credit losses of US$691 and US$334 as of December 31, 2024 and 2025, respectively)
Prepayments and other current assets (Allowance for current expected credit losses and impairment of US$6,223 and US$5,516 as of December 31, 2024 and 2025, respectively)
Held-for-sale assets
Total current assets

Non-current assets:
Long-term investments
Deferred tax assets
Property and equipment, net
Operating lease assets
Intangible assets, net
Goodwill
Other long-term prepayments and non-current assets
Due from a related party (Allowance for current expected credit losses of USD689 and nil as of December 31, 2021 and 2022, respectively)
Due from a related party (Allowance for current expected credit losses of nil and US$174 as of December 31, 2024 and 2025, respectively)
Long-term prepayments and other assets
Restricted cash

Total assets
Liabilities
Current liabilities (including amounts of the consolidated variable interest entity and its subsidiaries ("VIEs") without recourse to the Company of US$185,762 and US$256,407 as of December 31, 2024 and 2025, respectively)
Accounts payable
Due to related parties (including due to related parties of the consolidated VIEs without recourse to the Company of USD91 and nil as of December 31, 2021 and 2022, respectively)
Contract liabilities and deferred income, current portion (including contract liabilities and deferred income, current portion of the consolidated VIEs without recourse to the Company of USD36,740 and USD37,781 as of December 31, 2021 and 2022, respectively)
Due to related parties
Contract liabilities, current portion
Income tax payable
Accrued liabilities and other payables
Total current liabilities, excluding Held-for-sale for liabilities
Held-for-sale liabilities (including held-for-sale liabilities of the consolidated VIE and its subsidiaries without recourse to the Company of USD 3,309 and nil as of December 31, 2018 and 2019, respectively)
Short-term borrowings and current portion of long-term borrowings
Lease liabilities
Total current liabilities.

Non-current liabilities (including amounts of the consolidated VIEs without recourse to the Company of US$97,997 and US$119,707 as of December 31, 2024 and 2025, respectively)
Contract liabilities and deferred income (including contract liabilities and deferred income, non-current portion of the consolidated VIEs without recourse to the Company of USD845 and USD876 as of December 31, 2021 and 2022, respectively)
Deferred tax liabilities (including deferred tax liabilities of the consolidated VIE and its subsidiaries without recourse to the Company of USD nil and USD 1,366 as of December 31, 2017 and 2018, respectively)
Due to related parties, non-current portion
Other long-term payable
Contract liabilities
Deferred tax liabilities
Long-term borrowings
Other long-term payables
Lease liabilities

Total liabilities
Equity
Common shares (375,001,940 shares issued and 307,351,196 shares outstanding as of December 31, 2024; 375,001,940 shares issued and 314,277,001 shares outstanding as of December 31, 2025)
Treasury shares (67,650,744 shares and 60,724,939 shares as of December 31, 2024 and 2025, respectively)
Additional paid-in-capital
Statutory reserves
Treasury shares (35,233,649 shares and 32,354,429 shares as of December 31, 2017 and 2018, respectively)
Accumulated other comprehensive loss
(Accumulated deficits)/retained earnings
Total Xunlei Limited's shareholders' equity

Non-controlling interests
Total liabilities and shareholders' equity

Comments